Skip to main content
. 2023 Feb 1;12(2):97–111. doi: 10.1093/stcltm/szac088

Table 2.

Baseline characteristics of animals receiving placebo or cell therapy with umbilical cord tissue-derived mesenchymal stromal cells (UC-MSC).

Placebo (n = 5) UC-MSC (n = 8)
Phenotypical characteristics: no. (%)
 Papio anubis × Papio cynocephalus 3 (60) 5 (63)
 Female 3 (60) 5 (63)
 Singletons 5 (100) 8 (100)
Perinatal characteristics: no. (%)
 Complicated pregnancy course* 0 (0) 0 (0)
 Complete RDS-prophylaxis 5 (100) 7 (88)
Perinatal characteristics: mean (range)
 Gestational age at birth [day] 126 (125-127) 126 (124-128)
 Birth weight [g] 367 (326-386) 372 (332-404)
Baseline vital parameters: mean (CI95%)
 SpO2 [%] 91 (86-97) 92 (89-96)
 FiO2 0.40 (0.21-0.64) 0.29 (0.21-0.37)
 Mean airway pressure [cmH2O] 12.0 (11.8-12.2) 11.6 (11.1-12.1)
 Mean arterial blood pressure [mmHg] 36 (35-37) 31 (25-37)
 Heart rate [min−1] 169 (160-178) 171 (158-184)

*Infections, gestational diabetes, vaginal bleeding, or discordant growth of the fetus.

Averaged over 60 minutes prior to administration of MSC or placebo. No significant (P < .05) differences between groups for any of the parameters by Fisher’s exact or Welch’s unequal variance t-test. Abbreviations: RDS, respiratory distress syndrome; CI95%, 95% confidence interval of the mean; SpO2, peripheral oxygen saturation; FiO2, fraction of inspired oxygen.